课题基金 / 基金详情

A Study of Muscarinic Receptors in Brain Tissue Obtained Postmortem from Subjects with Schizophrenia

A Study of Muscarinic Receptors in Brain Tissue Obtained Postmortem from Subjects with Schizophrenia
精神分裂症患者死后脑组织中毒蕈碱受体的研究
批准号:
nhmrc : 209046
负责人:
Prof Brian Dean
金额:
$23.66万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31

项目摘要

项目成果

Prof Brian Dean的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The research outlined in this proposal will examine the molecular make up of certain regions of the human brain and determine if components within those regions are altered in tissue from subjects with schizophrenia. Schizophrenia is a serious psychiatric illness that affects approximately 1% of the Australian population and the research described in this proposal seeks to help understand the cause of the illness and-or to assist in the development of new drugs with which to treat the illness. The goal of the research outlined in this proposal is to determine if there are changes in specific molecules in the brain, termed muscarinic receptors. The muscarinic receptors are one way that a chemical in the brain called acetylcholine can communicate with the nerve cells in the brain. Acetylcholine is known to control important functions of the brain such as in memory, cognition and learning, all of these functions are thought to be affected in schizophrenia. Importantly, the control of all these functions involve muscarinic receptors and therefore, changes in those receptors could well produce some of the symptoms of schizophrenia. We now wish to extend our early studies which suggest there may be changes in muscarinic receptors in the brain of subjects with schizophrenia to determine which of the 5 muscarinic receptors are affected in which region of the brain by the pathology of the illness. From our existing data, we would predict that these studies will add weight to the argument that muscarinic receptors are altered in schizophrenia and provide vital information as to how drugs that target these receptors may be used to treat the illness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder
  • 批准号:
    nhmrc : 1078928
  • 项目类别:
    Project Grants
  • 资助金额:
    $32.19万
  • 财政年份:
    2015
  • 负责人:
    Prof Brian Dean
  • 依托单位:
Understanding the pathophysiology of schizophrenia, major depressive disorder and bipolar disorder as a basis for improving treatments
  • 批准号:
    nhmrc : 1002240
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $53.62万
  • 财政年份:
    2011
  • 负责人:
    Prof Brian Dean
  • 依托单位:
Understanding the Role of Muscarinic Receptors in the Pathophysiology of Depression and Bipolar Disorder
  • 批准号:
    nhmrc : 628669
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $32.01万
  • 财政年份:
    2010
  • 负责人:
    Prof Brian Dean
  • 依托单位:
Research Fellowship - Grant ID:400016
  • 批准号:
    nhmrc : 400016
  • 项目类别:
    NHMRC Research Fellowships
  • 资助金额:
    $40.48万
  • 财政年份:
    2006
  • 负责人:
    Prof Brian Dean
  • 依托单位:
海外基金